Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Day One Biopharmaceuticals (DAWN) Insider Trading & Ownership

Day One Biopharmaceuticals logo

Day One Biopharmaceuticals (NASDAQ:DAWN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$1.03M
Get DAWN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Day One Biopharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DAWN Insider Buying and Selling by Quarter

Day One Biopharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/17/2026
Adam Dubow
Adam Dubow
Insider
Sell6,395$11.60$74,182.00  
2/17/2026Sell6,065$11.60$70,354.00  
2/17/2026Sell15,459$11.60$179,324.40  
2/17/2026Sell5,814$11.60$67,442.40  
2/17/2026Sell2,728$11.60$31,644.80  
11/17/2025
Adam Dubow
Adam Dubow
Insider
Sell4,319$8.91$38,482.29  
11/17/2025Sell4,062$8.91$36,192.42  
11/17/2025Sell15,894$8.91$141,615.54  
11/17/2025Sell3,726$8.91$33,198.66  
8/18/2025
Adam Dubow
Adam Dubow
Insider
Sell4,365$6.77$29,551.05  
8/18/2025Sell4,106$6.77$27,797.62  
8/18/2025Sell16,058$6.77$108,712.66  
8/18/2025Sell3,766$6.77$25,495.82  
5/16/2025
Adam Dubow
Adam Dubow
General Counsel
Sell4,552$6.26$28,495.52  
5/16/2025Sell4,282$6.26$26,805.32  
5/16/2025Sell13,964$6.26$87,414.64  
5/16/2025Sell3,927$6.26$24,583.02  
(Data available from 1/1/2013 forward)

DAWN Insider Trading Activity - Frequently Asked Questions

6.20% of Day One Biopharmaceuticals stock is owned by insiders. Learn more on DAWN's insider holdings.

The following insiders have sold DAWN shares in the last 24 months: Adam Dubow ($323,413.26), Charles N York II ($293,290.56), Jeremy Bender ($937,293.16), Lauren Merendino ($150,719.90), Michael Vasconcelles ($31,644.80), Saira Ramasastry ($131,900.00), and Samuel C Blackman ($1,726,768.71).

Insiders have sold a total of 297,107 Day One Biopharmaceuticals shares in the last 24 months for a total of $3,595,030.39 sold.



This page (NASDAQ:DAWN) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners